Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease
-
Zeljko Romic
Abstract
Background: Patients with end-stage renal disease (ESRD) and on hemodialysis (HD) are at increased risk for developing rheumatoid arthritis (RA), as a result of defective immunity. Our aim was to examine if ESRD and the length of HD treatment impact the clinical utility of antibodies to cyclic citrullinated peptides (anti-CCP) and rheumatoid factor (RF) as diagnostic tools for RA.
Methods: We included 94 subjects in our study: 37 healthy volunteers and 57 patients with ESRD who had been undergoing HD for 1–12 years, and without confirmed RA. In order to test our hypothesis, we measured and correlated anti-CCP and RF as laboratory markers of RA.
Results: Our study showed that there is no significant difference between values for anti-CCP (p=0.11) and RF (p=0.98) in control subjects as well as in patients undergoing HD, regardless of the length of time that patients had been undergoing HD treatment.
Conclusions: Our study indicates that HD does not impair the specificity of anti-CCP and RF for RA in patients where the disease has not yet developed. Future prospective studies may show whether there is any use in determinating RF, and especially anti-CCP, as early predictors of RA in patients with ESRD who are at greater risk of developing this condition.
Clin Chem Lab Med 2009;47:959–62.
©2009 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Editorial
- Hemolysis index: quality indicator or criterion for sample rejection?
- Review
- Neutrophil CD64: a diagnostic marker for infection and sepsis
- Genetics and Molecular Diagnostics
- Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese
- Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia
- Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1
- General Clinical Chemistry and Laboratory Medicine
- Multicenter evaluation of the hemolysis index in automated clinical chemistry systems
- Haemolysis index – an estimate of preanalytical quality in primary health care
- Evaluation of the Innovance D-DIMER analytical performance
- Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
- Variation of barrier permeability for albumin and immunoglobulin G influx into cerebrospinal fluid
- Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease
- Reference Values and Biological Variations
- Quality of interpretative commenting on common clinical chemistry results in the Asia-Pacific region and Africa
- Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective
- Cancer Diagnostics
- HER1-4 protein concentrations in normal breast tissue from breast cancer patients are expressed by the same profile as in the malignant tissue
- Comparison of fifteen immunoassays for the measurement of serum MUC-1/CA 15-3 in breast cancer patients
- Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers
- Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
- Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study
- Letters to the Editor
- Clinical efficacy of two cardiac troponin I assays
- Impeded centrifugation in plasmocytoma serum
Artikel in diesem Heft
- Editorial
- Hemolysis index: quality indicator or criterion for sample rejection?
- Review
- Neutrophil CD64: a diagnostic marker for infection and sepsis
- Genetics and Molecular Diagnostics
- Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese
- Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia
- Clinical, biochemical, and genetic analysis of a Korean neonate with hereditary tyrosinemia type 1
- General Clinical Chemistry and Laboratory Medicine
- Multicenter evaluation of the hemolysis index in automated clinical chemistry systems
- Haemolysis index – an estimate of preanalytical quality in primary health care
- Evaluation of the Innovance D-DIMER analytical performance
- Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma
- Variation of barrier permeability for albumin and immunoglobulin G influx into cerebrospinal fluid
- Anti-citrullinated protein antibody and rheumatoid factor in patients with end-stage renal disease
- Reference Values and Biological Variations
- Quality of interpretative commenting on common clinical chemistry results in the Asia-Pacific region and Africa
- Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective
- Cancer Diagnostics
- HER1-4 protein concentrations in normal breast tissue from breast cancer patients are expressed by the same profile as in the malignant tissue
- Comparison of fifteen immunoassays for the measurement of serum MUC-1/CA 15-3 in breast cancer patients
- Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers
- Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid carcinoma
- Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia: a case-control study
- Letters to the Editor
- Clinical efficacy of two cardiac troponin I assays
- Impeded centrifugation in plasmocytoma serum
